Literature DB >> 4466653

[Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].

W Bruns, I Rjasanowski, P Wulfert, R Michael, S Knospe, W Hildmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4466653

Source DB:  PubMed          Journal:  Endokrinologie        ISSN: 0013-7251


× No keyword cloud information.
  2 in total

1.  Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen.

Authors:  H Lithell; J Boberg; H Hedstrand; K Hellsing; S Ljunghall; B Vessby
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

2.  [Bezafibrate in primary hyperlipidemias (author's transl)].

Authors:  J G Wechsler; V Hutt; H U Klör; G Bode; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1982-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.